Pearce Urology Ltd - Accounts to registrar (filleted) - small 18.2
Pearce Urology Ltd - Accounts to registrar (filleted) - small 18.2
| REGISTERED NUMBER: |
| Unaudited Financial Statements for the Year Ended 31 July 2019 |
| for |
| Pearce Urology Ltd |
| Pearce Urology Ltd (Registered number: 07700771) |
| Contents of the Financial Statements |
| for the Year Ended 31 July 2019 |
| Page |
| Balance Sheet | 1 |
| Notes to the Financial Statements | 3 |
| Pearce Urology Ltd (Registered number: 07700771) |
| Balance Sheet |
| 31 July 2019 |
| 2019 | 2018 |
| Notes | £ | £ |
| FIXED ASSETS |
| Tangible assets | 4 |
| Investments | 5 |
| Investment property | 6 |
| CURRENT ASSETS |
| Debtors | 7 |
| Investments | 8 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 9 | ( |
) | ( |
) |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| PROVISIONS FOR LIABILITIES | ( |
) | ( |
) |
| NET ASSETS |
| CAPITAL AND RESERVES |
| Called up share capital | 10 |
| Retained earnings |
| SHAREHOLDERS' FUNDS |
| The directors acknowledge their responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| Pearce Urology Ltd (Registered number: 07700771) |
| Balance Sheet - continued |
| 31 July 2019 |
| In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered. |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| Pearce Urology Ltd (Registered number: 07700771) |
| Notes to the Financial Statements |
| for the Year Ended 31 July 2019 |
| 1. | COMPANY INFORMATION |
| Pearce Urology Ltd is a |
| Wales. The company's registered number and registered office address are as below: |
| Registered number: | 07700771 |
| Registered office: | 49 Peter Street |
| Manchester |
| M2 3NG |
| The presentation currency of the financial statements is the Pound Sterling (£). |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Turnover |
| Turnover is measured at the fair value of the consideration received or receivable, excluding |
| discounts, rebates, value added tax and other sales taxes. |
| Revenue from the provision of professional services is recognised on delivery of the service. |
| Tangible fixed assets |
| Tangible fixed assets are initially measured at cost and subsequently measured at cost or |
| valuation net of depreciation and any impairment loss. |
| Depreciation is recognised so as to write-off the cost or valuation of assets less their residual |
| values over their useful lives on the following basis: |
| Fixtures and Fittings - 25% on cost |
| The gain or loss arising on disposal of an asset is determined as the difference between the |
| sales proceeds and the carrying value of the asset and is credited or charged to the profit or |
| loss. |
| Pearce Urology Ltd (Registered number: 07700771) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 July 2019 |
| 2. | ACCOUNTING POLICIES - continued |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement |
| of Income and Retained Earnings, except to the extent that it relates to items recognised in |
| other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that |
| have been enacted or substantively enacted by the balance sheet date. |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not |
| reversed at the balance sheet date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in |
| periods different from those in which they are recognised in financial statements. Deferred |
| tax is measured using tax rates and laws that have been enacted or substantively enacted |
| by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it |
| is probable that they will be recovered against the reversal of deferred tax liabilities or other |
| future taxable profits. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was |
| 4. | TANGIBLE FIXED ASSETS |
| Fixtures |
| and |
| fittings |
| £ |
| COST |
| At 1 August 2018 |
| Additions |
| At 31 July 2019 |
| DEPRECIATION |
| At 1 August 2018 |
| Charge for year |
| At 31 July 2019 |
| NET BOOK VALUE |
| At 31 July 2019 |
| At 31 July 2018 |
| Pearce Urology Ltd (Registered number: 07700771) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 July 2019 |
| 5. | FIXED ASSET INVESTMENTS |
| Unlisted |
| investments |
| £ |
| COST OR VALUATION |
| At 1 August 2018 |
| Additions |
| Revaluations | ( |
) |
| At 31 July 2019 |
| NET BOOK VALUE |
| At 31 July 2019 |
| At 31 July 2018 |
| Cost or valuation at 31 July 2019 is represented by: |
| Unlisted |
| investments |
| £ |
| Valuation in 2017 | (2,277 | ) |
| Valuation in 2018 | 3,825 |
| Valuation in 2019 | (7,078 | ) |
| Cost | 45,831 |
| 40,301 |
| 6. | INVESTMENT PROPERTY |
| Total |
| £ |
| FAIR VALUE |
| At 1 August 2018 |
| Revaluations | (7,253 | ) |
| At 31 July 2019 |
| NET BOOK VALUE |
| At 31 July 2019 |
| At 31 July 2018 |
| Pearce Urology Ltd (Registered number: 07700771) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 July 2019 |
| 6. | INVESTMENT PROPERTY - continued |
| Fair value at 31 July 2019 is represented by: |
| £ |
| Valuation in 2018 | 30,223 |
| Valuation in 2019 | (7,254 | ) |
| Cost | 114,845 |
| 137,814 |
| 7. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2019 | 2018 |
| £ | £ |
| Trade debtors |
| S455 recoverable | 20,794 | - |
| Directors' current accounts | 63,826 | 81,542 |
| 8. | CURRENT ASSET INVESTMENTS |
| 2019 | 2018 |
| £ | £ |
| Unlisted investments | 10,820 | 10,220 |
| 9. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2019 | 2018 |
| £ | £ |
| Trade creditors |
| Tax |
| Accrued expenses |
| 10. | CALLED UP SHARE CAPITAL |
| Allotted, issued and fully paid: |
| Number: | Class: | Nominal | 2019 | 2018 |
| value: | £ | £ |
| Ordinary A | 60 | 60 | 60 |
| Ordinary B | 40 | 40 | 40 |
| Ordinary C | 1 | 1 | 1 |
| 101 | 101 |
| Pearce Urology Ltd (Registered number: 07700771) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 July 2019 |
| 10. | CALLED UP SHARE CAPITAL - continued |
| Ordinary A shares confer upon the holders the right to vote upon any resolution proposed at |
| any general meeting of the company. |
| Ordinary B shares and Ordinary C shares do not confer on the holders the right to vote upon |
| any resolution proposed at any general meeting of the company. |
| Ordinary C shares do not confer upon the holder distribution rights in the event of winding |
| up. |
| Each share class confers upon the holders a discretionary right to distribution via dividend. |
| 11. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES |
| The following advances and credits to directors subsisted during the years ended |
| 31 July 2019 and 31 July 2018: |
| 2019 | 2018 |
| £ | £ |
| Balance outstanding at start of year | ( |
) |
| Amounts advanced |
| Amounts repaid | ( |
) | ( |
) |
| Amounts written off | - | - |
| Amounts waived | - | - |
| Balance outstanding at end of year |
| 12. | CONTROL |
| The ultimate controlling party is Dr I Pearce by virtue of holding the entirety of the voting |
| share capital of the company. |